People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synchronicity Pharma, Inc. | — | Pharmaceuticals | Series B | $62.7M | $29.7M | 2018 |
Glenn B Batchelder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glenn B Batchelder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul B Humphries | 1 | 1 |
| Ross Bersot | 1 | 1 |
| Peter B Schultz | 1 | 1 |
| Steve B Kay | 1 | 1 |
| Frederick B Craves | 1 | 1 |
| Shuichi B Kurosaki | 1 | 1 |
| Hoyoung B Huh | 1 | 1 |
| Blair B Jackson | 1 | 1 |
| Shu B Kurosaki | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.